Clinical trial
Exploratory Study on EUS-guided Portal Vein CTCs and Their Subtypes Combined With Multi-omics Detection for Early Warning of Pancreatic Cancer Recurrence and Metastasis
NCT07448376 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Study on EUS-guided Portal Vein CTCs and Their Subtypes Combined With Multi-omics Detection for Early Warning of Pancreatic Cancer Recurrence and Metastasis
- Lead sponsor
- Huazhong University of Science and Technology
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 1, 2026
- Completion date
- December 30, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
borderline resectable pancreatic cancer, ctcs, eus, liver metastases, pancreatic cancer, relapse, resectable pancreatic cancers